Similar Search Results

Innovation and patenting activities of COVID-19 vaccines in WTO members : analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)

Chiang, Ting-Wei; Wu, Xiaoping - 2022 - Manuscript date: 18 January 2022

COVID-19 vaccines. These vaccines have accounted for 99% of the global COVID-19 vaccine production as of 31 December 2021 …

Persistent link: https://www.econbiz.de/10012818093

Drivers of COVID-19 vaccinations : vaccine delivery and delivery efficiency in the United States

Goel, Rajeev K.; Nelson, Michael A. - In: Netnomics : economic research and electronic networking 22 (2021) 1, pp. 53-69

Persistent link: https://www.econbiz.de/10012818094

Tweeting on COVID-19 pandemic in South Africa : LDA-based topic modelling approach

Mutanga, Murimo Bethel; Abayomi, Abdultaofeek - In: African journal of science, technology, innovation and … 14 (2022) 1, pp. 163-172

Persistent link: https://www.econbiz.de/10012820776

The tortoise and the hare : the race between vaccine rollout and new Covid variants

Turner, David; Égert, Balázs; Guillemette, Yvan; … - 2021

New variants of the virus are spreading which, together with seasonal effects, are estimated to be able to raise effective reproduction numbers by up to 90%. Meanwhile, many countries are rolling out vaccination programmes, but at varying speeds. Hence the race is on to beat the variants with...

Persistent link: https://www.econbiz.de/10012547063

Impfstoffmärkte, COVID-19 und gesundheitspolitische Maßnahmen: ordnungsökonomische Anmerkungen

Kuchinke, Björn A. - 2021

production of COVID-19 vaccines, the incentives for everyone involved are set in such a way that as much safer vaccine as … considerable extent. A significantly faster build-up of capacities and a significantly higher amount of vaccine is not to be … expected in the period under review, even through other forms of organization, such as a kind of "war economy". So the vaccine …

Persistent link: https://www.econbiz.de/10012652833

The macroeconomics of COVID-19 exit strategy : the case of Japan

Kubota, So - In: The Japanese economic review : the journal of the … 72 (2021) 4, pp. 651-682

Persistent link: https://www.econbiz.de/10012661448

A choice experiment assessment of stated early response to COVID-19 vaccines in the USA

Daziano, Ricardo A. - In: Health economics review 12 (2022) 1, pp. 1-16

supports the vaccine, country of origin, and when the vaccine was developed. Out-of-pocket cost was also considered as … characteristic of the vaccines to derive welfare measures. Results: All vaccine attributes had expected signs with significant … estimates. Vaccines developed in the USA and the UK were preferred to a hypothetical German vaccine, whereas a Chinese origin …

Persistent link: https://www.econbiz.de/10013198760

Vaccination under the pandemic and political support

Takahashi, Masaki; Takaku, Reo; Ashida, Toyo; Ibuka, Yōko - 2022

Persistent link: https://www.econbiz.de/10013284045

COVID-19 vaccine rollout-scale and speed carry different implications for corruption

Goel, Rajeev K.; Nelson, Michael A.; Goel, Viraat Y. - In: Journal of policy modeling : JPMOD ; a social science … 43 (2021) 3, pp. 503-520

Persistent link: https://www.econbiz.de/10012880057

Rationing of a scarce life-saving resource : public preferences for prioritizing COVID-19 vaccination

Luyten, Jeroen; Tubeuf, Sandy; Kessels, Roselinde - In: Health economics 31 (2022) 2, pp. 342-362

Persistent link: https://www.econbiz.de/10012795980